FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Production and Process Controls Learning Module

[ Price : $8.95]

CDRH consumer safety officer Vidya Gopal uses a Webcast to describe requirements in the production and process controls subsystem.

FDA, NIH Not Enforcing Clinical Trial Reporting: Report

[ Price : $8.95]

A Science investigative report details the large percentage of clinical trials that fail to meet legal requirements for submitting...

CGMP Violations at Health Pharma

[ Price : $8.95]

FDA warns Health Pharma about CGMP violations in its work as a contract manufacturer of finished drugs.

Crysvita sBLA Submitted for Tumor-Induced Osteomalacia

[ Price : $8.95]

Ultragenyx Pharmaceutical and Kyowa Kirin file a supplemental BLA for Crysvita (burosumab) for treating FGF23-related hypophosphat...

Latest FDA Warning Letters

[ Price : $8.95]

FDA releases its latest batch of Warning Letters that includes Health Pharma, Huaian Zongheng Bio-Tech and James W. Findling.

CGMP Violations at Huaian Zongheng Bio-Tech

[ Price : $8.95]

FDA warns Chinas Huaian Zongheng Bio-Tech about CGMP violations in its work as a contract producer of finished drugs.

Vifor Asks Complex Drug Copy Requirements

[ Price : $8.95]

Vifor asks FDA to restrict the approval pathway for harder-to-copy complex drugs such as its products treating iron deficiency.

FDA Denies Petition Seeking Valtoco NDA Rejection

[ Price : $8.95]

FDA denies a petition asking it not to approve an NDA for Neurelis Valtoco, and approves the NDA.

4 Ways to Reform FDA Drug Regulatory Reform

[ Price : $8.95]

Former FDA principal deputy commissioner Joshua Sharfstein calls for reforms to the agencys decades of drug regulation reform to i...

Personal Cancer Monitor Granted Breakthrough Status

[ Price : $8.95]

FDA grants ArcherDX a breakthrough device designation for its Personalized Cancer Monitoring technology for early-stage cancer tre...